MONDAY, Dec. 5, 2022 (HealthDay News) — Doctors give men and women different advice to head off heart disease, even though guidelines for both are the same. Men were 20% more likely to be prescribed statins to lower blood levels of bad cholesterol compared with women, a new study found.Continue Reading
MONDAY, Dec. 5, 2022 (HealthDay News) — While people’s immune system T-cells can still target the spike proteins of the COVID coronavirus, their power to do so is waning over time, researchers report. As the virus continues to mutate, T-cell recognition of newer variants may be lost, the researchers cautioned.Continue Reading
FRIDAY, Dec. 2, 2022 (HealthDay News) — It’s thought that for an HIV vaccine to be widely effective, it will have to spur the body to make special antibodies that can neutralize a broad range of HIV strains. Now scientists say they have taken an essential step in that direction.Continue Reading
FRIDAY, Dec. 2, 2022 (HealthDay News) — Costs for epilepsy medications in the United States are skyrocketing, outpacing inflation and straining federal insurers Medicare and Medicaid, according to new research. Spending on antiseizure medications more than doubled in eight years for the government insurers, largely because of third-generation and brand-nameContinue Reading
FRIDAY, Dec. 2, 2022 (HealthDay News) — Methamphetamine wreaks havoc on the heart, warns new research that shows heart failure rates linked to the illicit drug are on the rise around the world. Not only are these cases increasing, but they are more severe than traditional heart failure cases andContinue Reading
THURSDAY, Dec. 1, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Wednesday approved the first fecal microbiota treatment, aimed at helping adults battling tough-to-treat Clostridium difficile (C. diff) infections. “Today’s approval of Rebyota is an advance in caring for patients who have recurrent C. difficile infection [CDI],”Continue Reading
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — Growing numbers of older Americans are dying from drug overdoses and alcohol abuse. That’s the tragic takeaway from two new reports by the U.S. Centers for Disease Control and Prevention. More than 5,000 people aged 65 and older in the United States diedContinue Reading
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — An early surge in cold and flu cases has created shortages in key antiviral and antibiotic drugs needed for the annual “sick season,” pharmacists report. The antiviral flu drug Tamiflu is in short supply for both adults and children, in both its brandContinue Reading
TUESDAY, Nov. 29, 2022 (HealthDay News) — Teenagers and young adults who use benzodiazepines to treat insomnia may be at heightened risk of overdose, a new study finds. Benzodiazepines include anxiety medications like Ativan, Klonopin, Valium and Xanax, as well as prescription sleep aids such as estazolam (ProSom), triazolam (Halcion)Continue Reading
MONDAY, Nov. 28, 2022 (HealthDay News) – U.S. health officials are tracking a new COVID variant that’s a combination of two earlier Omicron subvariants. Known as XBB, this latest subvariant now represents 3.1% of new COVID cases throughout the U.S. and 5% of cases in the Northeast. Based on preliminaryContinue Reading
MONDAY, Nov. 28, 2022 (HealthDay News) — Steroid users, especially teen boys and young men, seem indifferent to the serious side effects and dependency associated with use of the drugs, a new study finds. “We’re seeing more young adults and adolescent boys engaging in risk behaviors, such as the useContinue Reading
MONDAY, Nov. 28, 2022 (HealthDay News) — When pregnant women contract COVID-19, one in 10 will have moderate, severe or even critical symptoms, a new study finds. So it’s important they get their COVID vaccines, experts say. “Given that patients in all trimesters of pregnancy are susceptible to infection andContinue Reading
WEDNESDAY, Nov. 23, 2022 (HealthDay News) — People with one form of the genetic blood disorder hemophilia now have a one-time treatment with a $3.5 million price tag. The U.S. Food and Drug Administration approved the new gene therapy Hemgenix on Nov. 22. Soon after, drugmaker CSL Behring revealed itsContinue Reading
WEDNESDAY, Nov. 23, 2022 (HealthDay News) — It’s not too late to get the latest COVID-19 booster shot. Whether it’s the bivalent vaccine from drug maker Pfizer or from Moderna, the shots offer more protection against symptomatic infection, public health officials reiterated at a White House briefing on Tuesday. However,Continue Reading